Back to search

Article

DDX3X mediates EGFR-TKI resistance through VEGFR signaling

2021-12-01

Abstract excerpt

Although epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are remarkably effective against non-small-cell lung cancer (NSCLC) with EGFR -activating mutations, lung cancer cells acquire resistance to EGFR-TKIs without exception. Several mechanisms of EGFR-TKI resistance have been reported, but there are many aspects that remain to be clarified. We previously identified DDX3X as an immunogen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8a7318e6-557a-5531-aeca-5f05189ca1fa
DOI
10.21203/rs.3.rs-1073662/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
DDX3X mediates EGFR-TKI resistance through VEGFR signalingDOI 10.21203/rs.3.rs-1073662/v1
Select a neighboring publication to make it the new centre.